Cargando…
The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015
Background: Conclusive information regarding the influence of race on survival among neuroblastoma patients is limited. Our objective is to investigate the association between race and cause-specific survival in pediatric patients diagnosed with neuroblastoma in the US between 1973 and 2015. Methods...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399799/ https://www.ncbi.nlm.nih.gov/pubmed/32679868 http://dx.doi.org/10.3390/ijerph17145119 |
_version_ | 1783566215152664576 |
---|---|
author | Farouk, Farouk S. Viqar, Omar A. Sheikh, Zaid Castro, Grettel Barengo, Noël C. |
author_facet | Farouk, Farouk S. Viqar, Omar A. Sheikh, Zaid Castro, Grettel Barengo, Noël C. |
author_sort | Farouk, Farouk S. |
collection | PubMed |
description | Background: Conclusive information regarding the influence of race on survival among neuroblastoma patients is limited. Our objective is to investigate the association between race and cause-specific survival in pediatric patients diagnosed with neuroblastoma in the US between 1973 and 2015. Methods: This was a retrospective cohort study using the Surveillance, Epidemiology, and End Result (SEER) database. Patients aged 17 and younger of black, white, or Asian Pacific Islander (API) race diagnosed with neuroblastoma from 1973–2015 were included (n = 2,119). The outcome variable was time from diagnosis to death. Covariates included age, gender, ethnicity, stage, tumor site, and year of diagnosis. Cox proportional hazard models were used to calculate hazard ratios and 95% confidence intervals. Results: There were no statistically significant differences in the hazard of survival for blacks (HR 0.93; 95% confidence interval (CI) 0.74–1.16) or API (HR 1.02; 95% CI 0.76–1.37) compared with whites. However, patients diagnosed between 2000–2004 (HR 0.46; 95% CI 0.36–0.59) and 2005–2015 (HR 0.33; 95% CI 0.26–0.41) had decreased hazards of death when compared to patients treated during 1973 to 1999. Conclusions: No association between race and survival time was found. However, survival improved among all patients treated during 2000–2004 and 2005–2015 compared with those treated before the year 2000, leading to a narrowing of the racial disparity based on survival. |
format | Online Article Text |
id | pubmed-7399799 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73997992020-08-17 The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015 Farouk, Farouk S. Viqar, Omar A. Sheikh, Zaid Castro, Grettel Barengo, Noël C. Int J Environ Res Public Health Article Background: Conclusive information regarding the influence of race on survival among neuroblastoma patients is limited. Our objective is to investigate the association between race and cause-specific survival in pediatric patients diagnosed with neuroblastoma in the US between 1973 and 2015. Methods: This was a retrospective cohort study using the Surveillance, Epidemiology, and End Result (SEER) database. Patients aged 17 and younger of black, white, or Asian Pacific Islander (API) race diagnosed with neuroblastoma from 1973–2015 were included (n = 2,119). The outcome variable was time from diagnosis to death. Covariates included age, gender, ethnicity, stage, tumor site, and year of diagnosis. Cox proportional hazard models were used to calculate hazard ratios and 95% confidence intervals. Results: There were no statistically significant differences in the hazard of survival for blacks (HR 0.93; 95% confidence interval (CI) 0.74–1.16) or API (HR 1.02; 95% CI 0.76–1.37) compared with whites. However, patients diagnosed between 2000–2004 (HR 0.46; 95% CI 0.36–0.59) and 2005–2015 (HR 0.33; 95% CI 0.26–0.41) had decreased hazards of death when compared to patients treated during 1973 to 1999. Conclusions: No association between race and survival time was found. However, survival improved among all patients treated during 2000–2004 and 2005–2015 compared with those treated before the year 2000, leading to a narrowing of the racial disparity based on survival. MDPI 2020-07-15 2020-07 /pmc/articles/PMC7399799/ /pubmed/32679868 http://dx.doi.org/10.3390/ijerph17145119 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Farouk, Farouk S. Viqar, Omar A. Sheikh, Zaid Castro, Grettel Barengo, Noël C. The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015 |
title | The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015 |
title_full | The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015 |
title_fullStr | The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015 |
title_full_unstemmed | The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015 |
title_short | The Association between Race and Survival among Pediatric Patients with Neuroblastoma in the US between 1973 and 2015 |
title_sort | association between race and survival among pediatric patients with neuroblastoma in the us between 1973 and 2015 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399799/ https://www.ncbi.nlm.nih.gov/pubmed/32679868 http://dx.doi.org/10.3390/ijerph17145119 |
work_keys_str_mv | AT faroukfarouks theassociationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015 AT viqaromara theassociationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015 AT sheikhzaid theassociationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015 AT castrogrettel theassociationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015 AT barengonoelc theassociationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015 AT faroukfarouks associationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015 AT viqaromara associationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015 AT sheikhzaid associationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015 AT castrogrettel associationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015 AT barengonoelc associationbetweenraceandsurvivalamongpediatricpatientswithneuroblastomaintheusbetween1973and2015 |